# Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/secondary-cytoreduction-followed-by-chemotherapy-versus-chemotherapy-alone-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tingyan Shi,Jianqing Zhu,Yanling Feng,Dongsheng Tu,Yuqin Zhang,Zhang Ping,Huixun Jia,Xiao Huang,Yunlang Cai,Sheng Yin,Rong Jiang,Wenjuan Tian,Wen Gao,Jihong Liu,Huijuan Yang,Xi Cheng,Rongyu Zang |
| Citations | 229 |
| DOI | 10.1016/s1470-2045(21)00006-1 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3135376158 |
| PMID | 33705695 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jihong Liu](https://scholariq.org/researchers/jihong-liu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.